Literature DB >> 11665630

Isozyme-specific inhibitors and activators of protein kinase C.

Deborah Schechtman1, Daria Mochly-Rosen.   

Abstract

We describe here the methods we have used to generate selective peptide inhibitors and activators of PKC-mediated signaling. These approaches should be applicable to any signaling event that is dependent on protein-protein interaction. Furthermore, targeting downstream enzymes in signal transduction has been notoriously difficult as there are often families of related enzymes in each cell. The approaches we have used overcame this difficulty and may prove useful not only in basic research, but also in drug discovery.

Mesh:

Substances:

Year:  2002        PMID: 11665630     DOI: 10.1016/s0076-6879(02)45039-2

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  12 in total

1.  Use of a novel method to find substrates of protein kinase C delta identifies M2 pyruvate kinase.

Authors:  Stefan Siwko; Daria Mochly-Rosen
Journal:  Int J Biochem Cell Biol       Date:  2007-01-24       Impact factor: 5.085

2.  Rational design of a selective antagonist of epsilon protein kinase C derived from the selective allosteric agonist, pseudo-RACK peptide.

Authors:  Tamar Liron; Leon E Chen; Hanita Khaner; Alice Vallentin; Daria Mochly-Rosen
Journal:  J Mol Cell Cardiol       Date:  2007-01-24       Impact factor: 5.000

3.  Preclinical development of a bifunctional cancer cell homing, PKCepsilon inhibitory peptide for the treatment of head and neck cancer.

Authors:  Liwei Bao; Michael A Gorin; Manchao Zhang; Alejandra C Ventura; William C Pomerantz; Sofia D Merajver; Theodoros N Teknos; Anna K Mapp; Quintin Pan
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

4.  Protein kinase Cgamma mediates ethanol withdrawal hyper-responsiveness of NMDA receptor currents in spinal cord motor neurons.

Authors:  Hui-Fang Li; Daria Mochly-Rosen; Joan J Kendig
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

5.  PKCε activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting.

Authors:  Martina Monti; Sandra Donnini; Lucia Morbidelli; Antonio Giachetti; Daria Mochly-Rosen; Paolo Mignatti; Marina Ziche
Journal:  J Mol Cell Cardiol       Date:  2013-07-20       Impact factor: 5.000

6.  Structural Analysis of Hippocampal Kinase Signal Transduction.

Authors:  Daniel B McClatchy; Nam-Kyung Yu; Salvador Martínez-Bartolomé; Reesha Patel; Alexander R Pelletier; Mathieu Lavalle-Adam; Susan B Powell; Marisa Roberto; John R Yates
Journal:  ACS Chem Neurosci       Date:  2018-08-13       Impact factor: 4.418

7.  Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma.

Authors:  Juliette Martin; Fabrice Magnino; Karin Schmidt; Anne-Christine Piguet; Ju-Seog Lee; David Semela; Marie V St-Pierre; Andrew Ziemiecki; Doris Cassio; Charles Brenner; Snorri S Thorgeirsson; Jean-François Dufour
Journal:  Gastroenterology       Date:  2006-06       Impact factor: 22.682

8.  Modulation of the protein kinase Cdelta interaction with the "d" subunit of F1F0-ATP synthase in neonatal cardiac myocytes: development of cell-permeable, mitochondrially targeted inhibitor and facilitator peptides.

Authors:  Tiffany T Nguyen; Mourad Ogbi; Qilin Yu; Jordan B Fishman; Warren Thomas; Brian J Harvey; David Fulton; John A Johnson
Journal:  J Biol Chem       Date:  2010-05-11       Impact factor: 5.157

9.  Bryostatin 1 inhibits phorbol ester-induced apoptosis in prostate cancer cells by differentially modulating protein kinase C (PKC) delta translocation and preventing PKCdelta-mediated release of tumor necrosis factor-alpha.

Authors:  Vivian A von Burstin; Liqing Xiao; Marcelo G Kazanietz
Journal:  Mol Pharmacol       Date:  2010-06-01       Impact factor: 4.436

10.  Dopamine and ethanol cause translocation of epsilonPKC associated with epsilonRACK: cross-talk between cAMP-dependent protein kinase A and protein kinase C signaling pathways.

Authors:  Lina Yao; Peidong Fan; Zhan Jiang; Adrienne Gordon; Daria Mochly-Rosen; Ivan Diamond
Journal:  Mol Pharmacol       Date:  2008-01-17       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.